| Product Name | Molnupiravir (Synonyms: EIDD-2801; MK-4482) |
|---|---|
| CAS | 2349386-89-4 |
| Formula | C13H19N3O7 |
| MW | 329.31 |
| Appearance | Off-white powder |
| Storage condition | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 2 mg | In-stock | ¥168.00 | Visible after login | |
| 5 mg | In-stock | ¥306.00 | Visible after login | |
| 10 mg | In-stock | ¥526.00 | Visible after login | |
| 25 mg | In-stock | ¥706.00 | Visible after login | |
| 50 mg | In-stock | ¥916.00 | Visible after login | |
| 100 mg | In-stock | ¥1568.00 | Visible after login | |
| 250 mg | In-stock | ¥2688.00 | Visible after login | |
| 500 mg | In-stock | ¥4566.00 | Visible after login | |
| 1 g | In-stock | ¥6658.00 | Visible after login |
| Product Name | Molnupiravir (Synonyms: EIDD-2801; MK-4482) |
|---|---|
| CAS | 2349386-89-4 |
| Formula | C13H19N3O7 |
| MW | 329.31 |
| Appearance | Off-white powder |
| Storage condition | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19.
PMID: 32253226 PMCID: PMC7164393 DOI: 10.1126/scitranslmed.abb5883
PMID: 31645453 PMCID: PMC6848974 DOI: 10.1126/scitranslmed.aax5866